From April 1, 2024 to May 23, 2024, the company has repurchased 3,764,600 shares, representing 0.42% for CNY 59.9 million. With this, the company has completed the repurchase of 5,789,800 shares, representing 0.64% for CNY 99.89 million under the buyback announced on January 5, 2024.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
13.29 CNY | -2.92% |
|
+2.86% | -45.11% |
05-24 | Tranche Update on Zhejiang Jiuzhou Pharmaceutical Co., Ltd's Equity Buyback Plan announced on January 5, 2024. | CI |
05-23 | Jiuzhou Pharmaceutical Plans CRO in Germany | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-45.11% | 1.65B | |
+63.05% | 856B | |
+38.93% | 631B | |
-4.78% | 359B | |
+17.52% | 325B | |
+8.43% | 297B | |
+13.87% | 244B | |
+5.03% | 234B | |
+16.27% | 226B | |
+14.63% | 177B |
- Stock Market
- Equities
- 603456 Stock
- News Zhejiang Jiuzhou Pharmaceutical Co., Ltd
- Tranche Update on Zhejiang Jiuzhou Pharmaceutical Co., Ltd's Equity Buyback Plan announced on January 5, 2024.